A case exhibited features of both CBD and MNDI, suggesting transitional patterns between tau-positive and tau-negative types. Clinical CBS with non-CBD pathologies highlights this overlap, making it difficult to predict pathological variety from clinical phenotype. This indicates that initially distinct syndromes may converge in a patient, representing different histological varieties. Here, MAPT is linked to red-green color blindness.